Stoke Therapeutics, Inc. (STOK)
Nasdaq: STOK · CIK 0001623526 · United States
Every official Stoke Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open STOK filings
Stoke Therapeutics, Inc. documents
- Stoke Therapeutics, Inc. 10-K 2026STOK 10-K 2026: annual report for fiscal 2026
- Stoke Therapeutics, Inc. 10-K 2025STOK 10-K 2025: annual report for fiscal 2025
- Stoke Therapeutics, Inc. 10-K 2024STOK 10-K 2024: annual report for fiscal 2024
- Stoke Therapeutics, Inc. 10-K 2023STOK 10-K 2023: annual report for fiscal 2023
- Stoke Therapeutics, Inc. 10-K 2022STOK 10-K 2022: annual report for fiscal 2022
- Stoke Therapeutics, Inc. 10-Q 2026STOK 10-Q 2026: quarterly report for fiscal 2026
- Stoke Therapeutics, Inc. 10-Q 2025STOK 10-Q 2025: quarterly report for fiscal 2025
- Stoke Therapeutics, Inc. 10-Q 2024STOK 10-Q 2024: quarterly report for fiscal 2024
- Stoke Therapeutics, Inc. 10-Q 2023STOK 10-Q 2023: quarterly report for fiscal 2023
- Stoke Therapeutics, Inc. 10-Q 2022STOK 10-Q 2022: quarterly report for fiscal 2022
- Stoke Therapeutics, Inc. 8-K 2026STOK 8-K 2026: current report for fiscal 2026
- Stoke Therapeutics, Inc. 8-K 2025STOK 8-K 2025: current report for fiscal 2025
- Stoke Therapeutics, Inc. 8-K 2024STOK 8-K 2024: current report for fiscal 2024
- Stoke Therapeutics, Inc. 8-K 2023STOK 8-K 2023: current report for fiscal 2023
- Stoke Therapeutics, Inc. 8-K 2022STOK 8-K 2022: current report for fiscal 2022
- Stoke Therapeutics, Inc. DEF 14A 2026STOK DEF 14A 2026: proxy statement for fiscal 2026
- Stoke Therapeutics, Inc. DEF 14A 2025STOK DEF 14A 2025: proxy statement for fiscal 2025
- Stoke Therapeutics, Inc. DEF 14A 2024STOK DEF 14A 2024: proxy statement for fiscal 2024
- Stoke Therapeutics, Inc. DEF 14A 2023STOK DEF 14A 2023: proxy statement for fiscal 2023
- Stoke Therapeutics, Inc. DEF 14A 2022STOK DEF 14A 2022: proxy statement for fiscal 2022
- Stoke Therapeutics, Inc. Form 4 2026STOK Form 4 2026: insider trading filing for fiscal 2026
- Stoke Therapeutics, Inc. Form 4 2025STOK Form 4 2025: insider trading filing for fiscal 2025
- Stoke Therapeutics, Inc. Form 4 2024STOK Form 4 2024: insider trading filing for fiscal 2024
- Stoke Therapeutics, Inc. Form 4 2023STOK Form 4 2023: insider trading filing for fiscal 2023
- Stoke Therapeutics, Inc. Form 4 2022STOK Form 4 2022: insider trading filing for fiscal 2022
- Stoke Therapeutics, Inc. S-1 2026STOK S-1 2026: registration statement for fiscal 2026
- Stoke Therapeutics, Inc. S-1 2025STOK S-1 2025: registration statement for fiscal 2025
- Stoke Therapeutics, Inc. S-1 2024STOK S-1 2024: registration statement for fiscal 2024
- Stoke Therapeutics, Inc. S-1 2023STOK S-1 2023: registration statement for fiscal 2023
- Stoke Therapeutics, Inc. S-1 2022STOK S-1 2022: registration statement for fiscal 2022
- Stoke Therapeutics, Inc. 13F 2026STOK 13F 2026: institutional holdings for fiscal 2026
- Stoke Therapeutics, Inc. 13F 2025STOK 13F 2025: institutional holdings for fiscal 2025
- Stoke Therapeutics, Inc. 13F 2024STOK 13F 2024: institutional holdings for fiscal 2024
- Stoke Therapeutics, Inc. 13F 2023STOK 13F 2023: institutional holdings for fiscal 2023
- Stoke Therapeutics, Inc. 13F 2022STOK 13F 2022: institutional holdings for fiscal 2022
More companies